Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

HEMIN vs HEPARIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

HEMIN vs HEPARIN: Safety Overview

Metric HEMIN HEPARIN
Total FAERS Reports 359 18,167
Deaths Reported 17 3,150
Death Rate 4.7% 17.3%
Hospitalizations 78 7,788
Average Patient Age 36.9 yrs 61.3 yrs
% Female Patients 78.9% 40.0%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Recordati Rare Diseases, Inc. Sagent Pharmaceuticals
Route INTRAVENOUS INTRAVENOUS
Marketing Status N/A Discontinued